368 - Clinical Outcomes of Ertapenem in Critically Ill Patients with Bacteremia Caused by ESBL-Producing Organisms: A Comparison of Normal/elevated and Low Albumin Levels

Rapid Fire Presenter(s)

• 

  Brian Chung, PharmD

  Pharmacy Resident
  Long Island Jewish Medical Center
  Flushing, NY, United States

Co-Author(s)

• BK

  Barbara Kamel, PharmD

  Clinical Pharmacy Specialist
  Long Island Jewish Medical Center
  New Hyde Park, New York, United States
• 

  Kirby An, PharmD (he/him/his)

  Pharmacy Resident
  Long Island Jewish Medical Center/North Shore University Hospital
  New Hyde Park, New York, United States
• HD

  Henry Donaghy, MD

  Fellowship Director
  Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dayton and Karen Brown Division of Infectious Diseases
  New Hyde Park, New York, United States
• JR

  Juby Roy, DO

  Fellow
  Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dayton and Karen Brown Division of Infectious Diseases
  New Hyde Park, New York, United States
• RG

  Reshma George, DO

  Fellow
  Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dayton and Karen Brown Division of Infectious Diseases
  New Hyde Park, New York, United States
• AH

  Aya Haghamad, PharmD

  Pharmacy Advisor
  Northwell
  Lake Success, New York, United States
• TD

  Thien-Ly Doan, PharmD

  Clinical Pharmacy Specialist
  Long Island Jewish Medical Center
  New Hyde Park, NY, United States